(1->4)-beta-D-glucan multiple interactions ISO Arrdc2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ARRDC2 mRNA CTD PMID:36331819 1,2-dichloroethane decreases expression ISO Arrdc2 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of ARRDC2 mRNA CTD PMID:28189721 and PMID:28960355 1,2-dimethylhydrazine increases expression ISO Arrdc2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of ARRDC2 mRNA CTD PMID:22206623 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO ARRDC2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of ARRDC2 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ARRDC2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO ARRDC2 (Homo sapiens) 6480464 [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of ARRDC2 mRNA CTD PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Arrdc2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of ARRDC2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Arrdc2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of ARRDC2 mRNA CTD PMID:19465110 and PMID:19770486 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of ARRDC2 mRNA CTD PMID:28522335 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO ARRDC2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ARRDC2 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ARRDC2 mRNA CTD PMID:28628672 4-hydroxyphenyl retinamide increases expression ISO Arrdc2 (Mus musculus) 6480464 Fenretinide results in increased expression of ARRDC2 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO ARRDC2 (Homo sapiens) 6480464 Decitabine affects the expression of ARRDC2 mRNA CTD PMID:23300844 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of ARRDC2 mRNA CTD PMID:24780913 acrylamide increases expression ISO ARRDC2 (Homo sapiens) 6480464 Acrylamide results in increased expression of ARRDC2 mRNA CTD PMID:32763439 aflatoxin B1 increases expression ISO Arrdc2 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of ARRDC2 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO ARRDC2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of ARRDC2 promoter CTD PMID:30157460 aflatoxin B1 decreases expression ISO ARRDC2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of ARRDC2 mRNA CTD PMID:27153756 all-trans-retinoic acid decreases expression ISO ARRDC2 (Homo sapiens) 6480464 Tretinoin results in decreased expression of ARRDC2 mRNA CTD PMID:23724009 all-trans-retinoic acid increases expression ISO ARRDC2 (Homo sapiens) 6480464 Tretinoin results in increased expression of ARRDC2 mRNA CTD PMID:33167477 aristolochic acid A increases expression ISO ARRDC2 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of ARRDC2 mRNA CTD PMID:33212167 azathioprine increases expression ISO ARRDC2 (Homo sapiens) 6480464 Azathioprine results in increased expression of ARRDC2 mRNA CTD PMID:22623647 benzene increases expression ISO ARRDC2 (Homo sapiens) 6480464 Benzene results in increased expression of ARRDC2 mRNA CTD PMID:19162166 benzo[a]pyrene decreases expression ISO ARRDC2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of ARRDC2 mRNA CTD PMID:20106945 benzo[a]pyrene increases methylation ISO ARRDC2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of ARRDC2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO ARRDC2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of ARRDC2 mRNA CTD PMID:26238291 and PMID:32234424 benzo[a]pyrene increases expression ISO Arrdc2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of ARRDC2 mRNA CTD PMID:21569818 more ... benzo[a]pyrene decreases expression ISO Arrdc2 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of ARRDC2 mRNA CTD PMID:19770486 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ARRDC2 mRNA CTD PMID:18164116 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ARRDC2 mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO ARRDC2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ARRDC2 mRNA CTD PMID:28628672 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ARRDC2 mRNA CTD PMID:30816183 bisphenol F multiple interactions ISO ARRDC2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ARRDC2 mRNA CTD PMID:28628672 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of ARRDC2 mRNA CTD PMID:19167457 cadmium atom multiple interactions ISO ARRDC2 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARRDC2 mRNA CTD PMID:29741670 cadmium dichloride multiple interactions ISO ARRDC2 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARRDC2 mRNA CTD PMID:29741670 carbon nanotube decreases expression ISO Arrdc2 (Mus musculus) 6480464 Nanotubes and Carbon analog results in decreased expression of ARRDC2 mRNA CTD PMID:25554681 carbon nanotube affects expression ISO Arrdc2 (Mus musculus) 6480464 Nanotubes and Carbon affects the expression of ARRDC2 mRNA CTD PMID:25554681 and PMID:25620056 carmustine affects response to substance ISO ARRDC2 (Homo sapiens) 6480464 ARRDC2 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 chloroprene increases expression ISO Arrdc2 (Mus musculus) 6480464 Chloroprene results in increased expression of ARRDC2 mRNA CTD PMID:23125180 choline multiple interactions ISO Arrdc2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of ARRDC2 mRNA CTD PMID:20938992 cisplatin affects expression ISO ARRDC2 (Homo sapiens) 6480464 Cisplatin affects the expression of ARRDC2 mRNA CTD PMID:23300844 copper(II) sulfate increases expression ISO ARRDC2 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of ARRDC2 mRNA CTD PMID:19549813 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of ARRDC2 mRNA CTD PMID:27523638 cyclosporin A decreases expression ISO ARRDC2 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of ARRDC2 mRNA CTD PMID:20106945 cyclosporin A increases expression ISO ARRDC2 (Homo sapiens) 6480464 Cyclosporine results in increased expression of ARRDC2 mRNA CTD PMID:25562108 dexamethasone multiple interactions ISO ARRDC2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ARRDC2 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ARRDC2 mRNA CTD PMID:28628672 diazinon increases methylation ISO ARRDC2 (Homo sapiens) 6480464 Diazinon results in increased methylation of ARRDC2 gene CTD PMID:22964155 diethyl maleate decreases expression EXP 6480464 diethyl maleate results in decreased expression of ARRDC2 mRNA CTD PMID:21161181 dorsomorphin multiple interactions ISO ARRDC2 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of ARRDC2 mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO Arrdc2 (Mus musculus) 6480464 epoxiconazole results in decreased expression of ARRDC2 mRNA CTD PMID:35436446 ethanol affects expression ISO Arrdc2 (Mus musculus) 6480464 Ethanol affects the expression of ARRDC2 mRNA CTD PMID:30319688 folic acid multiple interactions ISO Arrdc2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of ARRDC2 mRNA CTD PMID:20938992 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ARRDC2 mRNA CTD PMID:33387578 glyphosate increases expression ISO Arrdc2 (Mus musculus) 6480464 glyphosate results in increased expression of ARRDC2 mRNA CTD PMID:35897073 hydrogen sulfide increases expression ISO Arrdc2 (Mus musculus) 6480464 Hydrogen Sulfide results in increased expression of ARRDC2 mRNA CTD PMID:31843631 indometacin multiple interactions ISO ARRDC2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ARRDC2 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ARRDC2 mRNA CTD PMID:28628672 isoprenaline increases expression ISO Arrdc2 (Mus musculus) 6480464 Isoproterenol results in increased expression of ARRDC2 mRNA CTD PMID:20003209 L-methionine multiple interactions ISO Arrdc2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of ARRDC2 mRNA CTD PMID:20938992 lead(0) affects expression ISO ARRDC2 (Homo sapiens) 6480464 Lead affects the expression of ARRDC2 mRNA CTD PMID:28903495 menadione affects expression ISO ARRDC2 (Homo sapiens) 6480464 Vitamin K 3 affects the expression of ARRDC2 mRNA CTD PMID:20044591 mercury dibromide decreases expression ISO ARRDC2 (Homo sapiens) 6480464 mercuric bromide results in decreased expression of ARRDC2 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO ARRDC2 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARRDC2 mRNA CTD PMID:27188386 methamphetamine increases expression ISO Arrdc2 (Mus musculus) 6480464 Methamphetamine results in increased expression of ARRDC2 mRNA CTD PMID:26307267 methyl methanesulfonate increases expression ISO ARRDC2 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of ARRDC2 mRNA CTD PMID:23649840 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ARRDC2 mRNA CTD PMID:18164116 niclosamide increases expression ISO ARRDC2 (Homo sapiens) 6480464 Niclosamide results in increased expression of ARRDC2 mRNA CTD PMID:36318118 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of ARRDC2 mRNA CTD PMID:23665939 ozone multiple interactions ISO Arrdc2 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ARRDC2 mRNA CTD PMID:34911549 paracetamol affects expression ISO Arrdc2 (Mus musculus) 6480464 Acetaminophen affects the expression of ARRDC2 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ARRDC2 mRNA CTD PMID:33387578 perfluorooctane-1-sulfonic acid multiple interactions ISO Arrdc2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ARRDC2 mRNA CTD PMID:36331819 phenobarbital increases expression ISO Arrdc2 (Mus musculus) 6480464 Phenobarbital results in increased expression of ARRDC2 mRNA CTD PMID:19270015 phenobarbital affects expression ISO Arrdc2 (Mus musculus) 6480464 Phenobarbital affects the expression of ARRDC2 mRNA CTD PMID:23091169 phenylmercury acetate decreases expression ISO ARRDC2 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of ARRDC2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO ARRDC2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARRDC2 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO Arrdc2 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ARRDC2 mRNA CTD PMID:19710929 propiconazole decreases expression ISO Arrdc2 (Mus musculus) 6480464 propiconazole results in decreased expression of ARRDC2 mRNA CTD PMID:21278054 quercetin increases expression ISO ARRDC2 (Homo sapiens) 6480464 Quercetin results in increased expression of ARRDC2 mRNA CTD PMID:21632981 SB 431542 multiple interactions ISO ARRDC2 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sunitinib increases expression ISO ARRDC2 (Homo sapiens) 6480464 Sunitinib results in increased expression of ARRDC2 mRNA CTD PMID:31533062 tamoxifen increases expression ISO Arrdc2 (Mus musculus) 6480464 Tamoxifen results in increased expression of ARRDC2 mRNA CTD PMID:25123088 temozolomide affects response to substance ISO ARRDC2 (Homo sapiens) 6480464 ARRDC2 mRNA affects the susceptibility to temozolomide CTD PMID:16365179 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of ARRDC2 mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO Arrdc2 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of ARRDC2 mRNA CTD PMID:31919559 tetraphene affects expression ISO Arrdc2 (Mus musculus) 6480464 benz(a)anthracene affects the expression of ARRDC2 mRNA CTD PMID:26377693 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of ARRDC2 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO Arrdc2 (Mus musculus) 6480464 titanium dioxide results in increased expression of ARRDC2 mRNA CTD PMID:27760801 triptonide increases expression ISO Arrdc2 (Mus musculus) 6480464 triptonide results in increased expression of ARRDC2 mRNA CTD PMID:33045310 troglitazone decreases expression ISO Arrdc2 (Mus musculus) 6480464 troglitazone results in decreased expression of ARRDC2 mRNA CTD PMID:28973697 urethane increases expression ISO ARRDC2 (Homo sapiens) 6480464 Urethane results in increased expression of ARRDC2 mRNA CTD PMID:28818685 valproic acid decreases expression ISO ARRDC2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of ARRDC2 mRNA CTD PMID:29154799 valproic acid increases methylation ISO ARRDC2 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of ARRDC2 gene CTD PMID:29154799 zinc atom multiple interactions ISO ARRDC2 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of ARRDC2 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO ARRDC2 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of ARRDC2 mRNA CTD PMID:18593933